Mercado de leucoféresis: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[Informe de investigación] Se prevé que el mercado de la leucoféresis alcance los 133,90 millones de dólares en 2028, desde los 74,48 millones de dólares de 2021; se estima que crecerá a una tasa compuesta anual del 8,7 % entre 2021 y 2028.

La leucoféresis es un procedimiento en el que los glóbulos blancos (leucocitos) participan en la respuesta inmunitaria del cuerpo. se separan de una muestra de sangre. Es una forma particular de aféresis en la que se obtiene un elemento de la sangre, como glóbulos rojos o plaquetas, mientras que el resto de la sangre se restablece a la circulación. La leucoféresis se utiliza a menudo para reducir recuentos muy altos de glóbulos blancos (WBC), como los cánceres de sangre crónicos como la leucemia linfocítica crónica (LLC). También se puede realizar para obtener glóbulos blancos para un trasplante posterior, como para controlar disminuciones abruptas en el recuento de glóbulos blancos durante la quimioterapia contra el cáncer. Otro uso es como parte de una nueva forma de inmunoterapia, denominada terapia de células T con receptor de antígeno quimérico (CAR), para ayudar a combatir la leucemia, el cáncer de próstata y otras formas de cáncer. La leucoféresis se puede realizar en la persona que solicita el tratamiento (aféresis autóloga) o en un donante para un trasplante posterior (aféresis alogénica). Actualmente, la leucoféresis se usa comúnmente para tratar diversas enfermedades y también se usa con fines de diagnóstico, ya que puede aumentar la producción de células tumorales circulantes. Factores como el creciente número de donantes voluntarios de sangre, la creciente incidencia de enfermedades hematológicas y el aumento de la población de edad avanzada están impulsando el crecimiento del mercado de la leucoféresis. Sin embargo, el alto costo de la leucoféresis obstruye el crecimiento del mercado hasta cierto punto.

regiones lucrativas para el mercado de leucoféresis


Perspectivas del mercado

La transfusión de sangre es una parte integral de la infraestructura y las políticas nacionales de salud de varios países. Los avances en la industria médica han llevado a mejoras en los procedimientos de tratamiento de enfermedades y lesiones graves, lo que eventualmente ha impulsado la necesidad de transfusiones de sangre para los pacientes. supervivencia. La creciente conciencia sobre la importancia de las transfusiones de sangre y la disponibilidad de sangre en los servicios de salud ha llevado a un aumento en el número de personas dispuestas a donar sangre por causas médicas. Según los datos de la Organización Mundial de la Salud (OMS), en 2018 se reportaron ~117,4 millones de donaciones de sangre en todo el mundo. Los donantes de sangre generalmente se clasifican en voluntarios no remunerados, remunerados y familiares/reemplazo, y según las afirmaciones de la OMS, donantes voluntarios/no remunerados. son la principal fuente de un suministro de sangre fiable y adecuado. Según datos de la OMS en 2019, las donaciones de sangre realizadas por donantes voluntarios no remunerados aumentaron en 11,6 millones entre 2008 y 2015 en 139 países del mundo. La tendencia de la donación de sangre también está ganando importancia en los países de ingresos bajos y medianos. Según los datos presentados durante la reunión anual del CAG de 2017, se realizaron ~13 000 procedimientos en 1087 pacientes en 2016. El mayor aumento en el número de donantes voluntarios de sangre se encontró en los países del sudeste asiático (83 %) y las Américas (70 %). .

Los programas nacionales desarrollados e implementados en muchos países están atrayendo aún más a un gran número de donantes de plaquetas y sangre. Por ejemplo, en la India, el Consejo Nacional de Transfusión de Sangre (NBTC), constituido dentro de la Organización Nacional de Control del SIDA (NACO), es el organismo central que coordina con los Consejos Estatales de Transfusión de Sangre (SBTC), establecidos dentro de las Sociedades Estatales de Control del SIDA. (SACS). La NBTC apoya programas de salud para diversas actividades relacionadas con los servicios de transfusión de sangre (BTS). Por lo tanto, el creciente número de donantes elegibles en diferentes países del mundo está fomentando la necesidad de equipos de leucoféresis que se utilicen para separar los componentes sanguíneos necesarios.

Tipo de producto- Información basada en:

Según el tipo de producto, el mercado de la leucoféresis se divide en dispositivos de leucoféresis y productos desechables de leucoféresis. En 2021, el segmento de productos desechables para leucoféresis tuvo una mayor participación de mercado. Sin embargo, se espera que el segmento de dispositivos de leucoféresis registre una CAGR más alta durante 2021 a 2028.

Mercado de leucoféresis, por tipo de producto: 2021 y 2028

Información basada en aplicaciones

El mercado de la leucoféresis, por aplicación, se divide en aplicaciones de investigación y terapéuticas. aplicaciones. En 2021, el segmento de aplicaciones de investigación tuvo una mayor participación de mercado y se espera que el mismo segmento registre una CAGR más alta durante los próximos años.

Usuario final- Información basada en

El mercado de la leucoféresis, por usuario final, está segmentado en empresas farmacéuticas y de biotecnología, institutos académicos y de investigación, proveedores de componentes sanguíneos y centros de sangre, y hospitales y centros de transfusión. En 2021, el segmento de proveedores de componentes sanguíneos y centros de sangre tuvo la mayor participación del mercado. Por otro lado, se espera que el segmento de hospitales y centros de transfusión registre la CAGR más alta durante los próximos años.

Perspectivas estratégicas

Empresas que operan en el mercado de la leucoféresis están adoptando estrategias como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y expansiones de la cartera de productos para expandir su presencia en todo el mundo, mantener la marca y satisfacer la creciente demanda de los usuarios finales.

< p> 

Mercado de leucoféresis – ndash; por tipo de producto

  • Dispositivos de leucoféresis
    • Dispositivos de aféresis
    • Columnas de leucoféresis y separadores celulares
    • Filtros de leucorreducción
    • Desechables de leucoféresis

    Mercado de leucoféresis - ndash; por aplicación

    • Aplicaciones de investigación
    • Aplicaciones terapéuticas

    Mercado de leucoféresis: ndash; por usuario final

    • Empresas farmacéuticas y de biotecnología
    • Institutos académicos y de investigación
    • Proveedores de componentes sanguíneos y centros de sangre
    • Hospitales y Centros de transfusión

    Mercado de leucoféresis – ndash; por Geografía

    • América del Norte
      • Estados Unidos
      • Canadá
      • México
    • < li>Europa
      • Francia
      • Alemania
      • Italia
      • Reino Unido
      • España
      • Resto de Europa
    • Asia Pacífico (APAC)
      • China
      • India
      • Corea del Sur
      • Japón
      • Australia
      • Resto de Asia Pacífico
    • Medio Oriente y Asia África (MEA)
      • Sudáfrica
      • Arabia Saudita
      • EAU
      • Resto de Medio Oriente y África África
    • América del Sur (SAM)
      • Brasil
      • Argentina
      • Resto de América del Sur y Central< /li>

    Perfiles de empresas

    • Asahi Kasei Corporation
    • Fresenius SE & Co. KGaA
    • Haemonetics Corporation
    • Terumo Corporation
    • STEMCELL Technologies Inc.
    • HemaCare
    • Macopharma
    • Todas las células
    • STEMEXPRESS
    • BioIVT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports